Limit by date

Facilitating microbiome analyses: InfectoGnostics researchers remove irrelevant DNA already during sequencing

InfectoGnostics researchers at Jena University Hospital (JUH) and the Leibniz Institute for Photonic Technology (Leibniz-IPHT) have been able to show how irrelevant human DNA can be sorted out already during sequencing with nanopore systems to enable more precise analyses of microbiomes and bring…

Read more
A positive PVL rapid test after being carried out in the laboratory of the InfectoGnostics research campus in Jena.

Staphylococcus aureus: Rapid test detects important virulence factor "PVL" in 15 minutes

InfectoGnostics scientists at the Leibniz Institute of Photonic Technologies (Leibniz-IPHT), together with partners from the United Arab Emirates (UAE), have successfully validated a lateral flow test that was previously developed together with InfectoGnostics' corporate partners Senova and fzmb. In…

Read more

Cross-Cluster Weeks Thuringia provide impulses for innovation

The Cross-Cluster Weeks Thuringia were again a complete success in 2021 with almost 800 participants. Topics like sustainable production, new materials, energy transition, resource efficiency, on-site analysis and therapy of infections or digitalization were discussed in a cross-sectoral exchange…

Read more
[Translate to English:]

Corona Genome Sequencing: Central German Company "nanozoo" Launches Portal for Free Data Analysis

The central German start-up company "nanozoo" – a member of the InfectoGnostics research campus in Jena – has launched a portal for the free analysis and processing of raw data from the genome sequencing of SARS-CoV-2 isolates. Within a few hours, the data of registered users will be processed and…

Read more

Antibody Test for Coronavirus Developed with InfectoGnostics Partners in Jena and Weimar

An international team of researchers, including two InfectoGnostics partners - the Leibniz Institute for Photonic Technologies (Leibniz-IPHT) in Jena and the diagnostics company Senova in Weimar - has developed a rapid antibody test for the new coronavirus. Using a blood sample, it shows within ten…

Read more

InfectoGnostics Clinician Interviewed: Precision Medicine 2.0

The right treatment for the right patient at the right time - this approach of "precision medicine" is increasingly being used in the prevention of infections and sepsis. In an interview with the "Infectious Diseases Hub", Prof. Mathias Pletz, leading infectiologist at the University Hospital of…

Read more

New Leibniz research centre in Jena: Photonics for the fight against resistant pathogens

The Federal Ministry of Education and Research (BMBF) is funding a new Leibniz Research Centre in Jena. Technology developers, physicians and medical technology manufacturers will bring light-based technologies for better diagnostics and therapy of infections from the idea to the application in the…

Read more
InfectoGnostics researcher preparing a sample for testing.

Study on hospital infections: Patients introduce resistant ESBL germs to hospitals

One in eight newly hospitalised patients is already a carrier of ESBL-forming bacteria, scientists from the InfectoGnostics Research Campus Jena have now proven in an observational study involving 1,334 patients. Although infections with the patient’s own ESBL pathogens remained an exception in the…

Read more

InfectoGnostics at MEDICA fair 2018

The InfectoGnostics Research Campus Jena presented itself at this year's MEDICA trade fair in Düsseldorf from November 12 to 15, 2018. The "RamanBioAssay" for photonic detection of antibiotic resistance was presented at the joint Middle German stand "Forschung für die Zukunft / Research for the…

Read more

Point-of-care testing for hepatitis C: InfectoGnostics partners receive funding from FIND

The Geneva Foundation for Innovative New Diagnostics (FIND) will fund feasibility studies on molecular point-of-care tests for hepatitis C by the two InfectoGnostics industrial partners Abbott (Alere Technologies) and BLINK. This was announced by FIND on 28 July, World Hepatitis Day.

Read more